Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Tetrud

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental methodP R Burkhard, H Shale, J W Langston, et al.
Neurology|November 1, 1989
Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)J W Tetrud, J W Langston, P L Garbe, et al.
Neurology|April 1, 1996
Autopsy-proven progressive supranuclear palsy in two siblingsJ W Tetrud, L I Golbe, L S Forno, et al.
Parkinsonism & Related Disorders|October 24, 2006
Novel features in a patient homozygous for the L347P mutation in the PINK1 geneJ Doostzadeh, J W Tetrud, M Allen-Auerbach, et al.
Neurology|May 1, 1993
Oral levodopa/carbidopa solution versus tablets in Parkinson's patients with severe fluctuations: a pilot studyM C Kurth, J W Tetrud, I Irwin, et al.
Neurology|February 1, 1990
Cognitive change following MPTP exposureY Stern, J W Tetrud, W R Martin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismB J Snow, F J Vingerhoets, J W Langston, et al.
Annals of Neurology|November 1, 1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesionsF J Vingerhoets, B J Snow, J W Tetrud, et al.
Journal of the Neurological Sciences|July 1, 1990
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseB R Bloem, I Irwin, O J Buruma, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental methodP R Burkhard, H Shale, J W Langston, et al.
Neurology|November 1, 1989
Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)J W Tetrud, J W Langston, P L Garbe, et al.
Neurology|April 1, 1996
Autopsy-proven progressive supranuclear palsy in two siblingsJ W Tetrud, L I Golbe, L S Forno, et al.
Parkinsonism & Related Disorders|October 24, 2006
Novel features in a patient homozygous for the L347P mutation in the PINK1 geneJ Doostzadeh, J W Tetrud, M Allen-Auerbach, et al.
Neurology|May 1, 1993
Oral levodopa/carbidopa solution versus tablets in Parkinson's patients with severe fluctuations: a pilot studyM C Kurth, J W Tetrud, I Irwin, et al.
Neurology|February 1, 1990
Cognitive change following MPTP exposureY Stern, J W Tetrud, W R Martin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismB J Snow, F J Vingerhoets, J W Langston, et al.
Annals of Neurology|November 1, 1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesionsF J Vingerhoets, B J Snow, J W Tetrud, et al.
Journal of the Neurological Sciences|July 1, 1990
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseB R Bloem, I Irwin, O J Buruma, et al.
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Pageof 3